449 related articles for article (PubMed ID: 20886109)
1. Catalytic function of PLA2G6 is impaired by mutations associated with infantile neuroaxonal dystrophy but not dystonia-parkinsonism.
Engel LA; Jing Z; O'Brien DE; Sun M; Kotzbauer PT
PLoS One; 2010 Sep; 5(9):e12897. PubMed ID: 20886109
[TBL] [Abstract][Full Text] [Related]
2. R632W mutation in PLA2G6 segregates with dystonia-parkinsonism in a consanguineous Iranian family.
Sina F; Shojaee S; Elahi E; Paisán-Ruiz C
Eur J Neurol; 2009 Jan; 16(1):101-4. PubMed ID: 19087156
[TBL] [Abstract][Full Text] [Related]
3. A new PLA2G6 mutation in a family with infantile neuroaxonal dystrophy.
Iannello G; Graziano C; Cenacchi G; Cordelli DM; Zuntini R; Papa V; Magistà AM; Gagliardi M; Procopio R; Quattrone A; Annesi G
J Neurol Sci; 2017 Oct; 381():209-212. PubMed ID: 28991683
[TBL] [Abstract][Full Text] [Related]
4. Genetic Analysis of PLA2G6 in 22 Indian Families with Infantile Neuroaxonal Dystrophy, Atypical Late-Onset Neuroaxonal Dystrophy and Dystonia Parkinsonism Complex.
Kapoor S; Shah MH; Singh N; Rather MI; Bhat V; Gopinath S; Bindu PS; Taly AB; Sinha S; Nagappa M; Bharath RD; Mahadevan A; Narayanappa G; Chickabasaviah YT; Kumar A
PLoS One; 2016; 11(5):e0155605. PubMed ID: 27196560
[TBL] [Abstract][Full Text] [Related]
5. Phenotype and genotype heterogeneity of PLA2G6-associated neurodegeneration in a cohort of pediatric and adult patients.
Dehnavi AZ; Bemanalizadeh M; Kahani SM; Ashrafi MR; Rohani M; Toosi MB; Heidari M; Hosseinpour S; Amini B; Zokaei S; Rezaei Z; Aryan H; Amanat M; Vahidnezhad H; Mohammadi P; Garshasbi M; Tavasoli AR
Orphanet J Rare Dis; 2023 Jul; 18(1):177. PubMed ID: 37403138
[TBL] [Abstract][Full Text] [Related]
6. Neuroaxonal dystrophy in PLA2G6 knockout mice.
Sumi-Akamaru H; Beck G; Kato S; Mochizuki H
Neuropathology; 2015 Jun; 35(3):289-302. PubMed ID: 25950622
[TBL] [Abstract][Full Text] [Related]
7. The role of the PLA2G6 gene in neurodegenerative diseases.
Deng X; Yuan L; Jankovic J; Deng H
Ageing Res Rev; 2023 Aug; 89():101957. PubMed ID: 37236368
[TBL] [Abstract][Full Text] [Related]
8. Mutation screening of PLA2G6 in Japanese patients with early onset dystonia-parkinsonism.
Yamashita C; Funayama M; Li Y; Yoshino H; Yamada H; Seino Y; Tomiyama H; Hattori N
J Neural Transm (Vienna); 2017 Apr; 124(4):431-435. PubMed ID: 27942883
[TBL] [Abstract][Full Text] [Related]
9. PLA2G6-associated late-onset parkinsonism in a Sudanese family.
Bakhit Y; Tesson C; Ibrahim MO; Eltom K; Eltazi I; Elsayed LEO; Lesage S; Seidi O; Corvol JC; Wüllner U;
Ann Clin Transl Neurol; 2023 Jun; 10(6):983-989. PubMed ID: 37139542
[TBL] [Abstract][Full Text] [Related]
10. A systematic analysis of genotype-phenotype associations with PLA2G6.
Xue J; Ding DX; Xu GY; Wang PZ; Ge YL; Zhang JR; Cheng XY; Wang YM; Jin H; Luo SY; Zheng YH; Chen J; Wang F; Li D; Mao CJ; Li K; Liu CF
Parkinsonism Relat Disord; 2023 Jul; 112():105477. PubMed ID: 37285793
[TBL] [Abstract][Full Text] [Related]
11. Neurons and astrocytes in an infantile neuroaxonal dystrophy (INAD) mouse model show characteristic alterations in glutamate-induced Ca
Strokin M; Reiser G
Neurochem Int; 2017 Sep; 108():121-132. PubMed ID: 28279750
[TBL] [Abstract][Full Text] [Related]
12. Disruption of Golgi morphology and altered protein glycosylation in PLA2G6-associated neurodegeneration.
Davids M; Kane MS; He M; Wolfe LA; Li X; Raihan MA; Chao KR; Bone WP; Boerkoel CF; Gahl WA; Toro C
J Med Genet; 2016 Mar; 53(3):180-9. PubMed ID: 26668131
[TBL] [Abstract][Full Text] [Related]
13. Novel splice-site mutations and a large intragenic deletion in PLA2G6 associated with a severe and rapidly progressive form of infantile neuroaxonal dystrophy.
Tonelli A; Romaniello R; Grasso R; Cavallini A; Righini A; Bresolin N; Borgatti R; Bassi MT
Clin Genet; 2010 Nov; 78(5):432-40. PubMed ID: 20584031
[TBL] [Abstract][Full Text] [Related]
14. Genotype-phenotype correlations of adult-onset PLA2G6-associated Neurodegeneration: case series and literature review.
Chu YT; Lin HY; Chen PL; Lin CH
BMC Neurol; 2020 Mar; 20(1):101. PubMed ID: 32183746
[TBL] [Abstract][Full Text] [Related]
15. Validation of the finding of hypertrophy of the clava in infantile neuroaxonal dystrophy/PLA2G6 by biometric analysis.
Al-Maawali A; Yoon G; Feigenbaum AS; Halliday WC; Clarke JT; Branson HM; Banwell BL; Chitayat D; Blaser SI
Neuroradiology; 2016 Oct; 58(10):1035-1042. PubMed ID: 27516098
[TBL] [Abstract][Full Text] [Related]
16. Neurodegeneration associated with genetic defects in phospholipase A(2).
Gregory A; Westaway SK; Holm IE; Kotzbauer PT; Hogarth P; Sonek S; Coryell JC; Nguyen TM; Nardocci N; Zorzi G; Rodriguez D; Desguerre I; Bertini E; Simonati A; Levinson B; Dias C; Barbot C; Carrilho I; Santos M; Malik I; Gitschier J; Hayflick SJ
Neurology; 2008 Oct; 71(18):1402-9. PubMed ID: 18799783
[TBL] [Abstract][Full Text] [Related]
17. Four novel rare mutations of PLA2G6 in Chinese population with Parkinson's disease.
Gui YX; Xu ZP; Wen-Lv ; Liu HM; Zhao JJ; Hu XY
Parkinsonism Relat Disord; 2013 Jan; 19(1):21-6. PubMed ID: 23182313
[TBL] [Abstract][Full Text] [Related]
18. Loss of PLA2G6 leads to elevated mitochondrial lipid peroxidation and mitochondrial dysfunction.
Kinghorn KJ; Castillo-Quan JI; Bartolome F; Angelova PR; Li L; Pope S; Cochemé HM; Khan S; Asghari S; Bhatia KP; Hardy J; Abramov AY; Partridge L
Brain; 2015 Jul; 138(Pt 7):1801-16. PubMed ID: 26001724
[TBL] [Abstract][Full Text] [Related]
19. Establishment of an improved mouse model for infantile neuroaxonal dystrophy that shows early disease onset and bears a point mutation in Pla2g6.
Wada H; Yasuda T; Miura I; Watabe K; Sawa C; Kamijuku H; Kojo S; Taniguchi M; Nishino I; Wakana S; Yoshida H; Seino K
Am J Pathol; 2009 Dec; 175(6):2257-63. PubMed ID: 19893029
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
